Ryvu Therapeutics S.A. (WSE:RVU)

Ryvu Therapeutics Statistics

Total Valuation

WSE:RVU has a market cap or net worth of PLN 436.86 million. The enterprise value is 626.87 million.

Market Cap	436.86M
Enterprise Value	626.87M

Important Dates

The next estimated earnings date is Tuesday, November 25, 2025.

Earnings Date	Nov 25, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:RVU has 18.36 million shares outstanding. The number of shares has increased by 11.48% in one year.

Current Share Class	14.31M
Shares Outstanding	18.36M
Shares Change (YoY)	+11.48%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	29.71%
Owned by Institutions (%)	59.32%
Float	12.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.36
PB Ratio	1.38
P/TBV Ratio	2.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.98
EV / Sales	4.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.05

Financial Position

The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.65.

Current Ratio	0.97
Quick Ratio	0.84
Debt / Equity	0.65
Debt / EBITDA	n/a
Debt / FCF	-1.65
Interest Coverage	-39.65

Financial Efficiency

Return on equity (ROE) is -40.24% and return on invested capital (ROIC) is -17.76%.

Return on Equity (ROE)	-40.24%
Return on Assets (ROA)	-13.62%
Return on Invested Capital (ROIC)	-17.76%
Return on Capital Employed (ROCE)	-22.51%
Revenue Per Employee	396,634
Profits Per Employee	-319,732
Employee Count	328
Asset Turnover	0.25
Inventory Turnover	3.88

Taxes

In the past 12 months, WSE:RVU has paid 2.34 million in taxes.

Income Tax	2.34M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.32% in the last 52 weeks. The beta is 0.59, so WSE:RVU's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-46.32%
50-Day Moving Average	27.13
200-Day Moving Average	28.26
Relative Strength Index (RSI)	34.62
Average Volume (20 Days)	34,924

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:RVU had revenue of PLN 130.10 million and -104.87 million in losses. Loss per share was -4.54.

Revenue	130.10M
Gross Profit	108.30M
Operating Income	-111.74M
Pretax Income	-102.53M
Net Income	-104.87M
EBITDA	-100.32M
EBIT	-111.74M
Loss Per Share	-4.54

Balance Sheet

The company has 14.41 million in cash and 204.42 million in debt, giving a net cash position of -190.01 million or -10.35 per share.

Cash & Cash Equivalents	14.41M
Total Debt	204.42M
Net Cash	-190.01M
Net Cash Per Share	-10.35
Equity (Book Value)	315.84M
Book Value Per Share	17.21
Working Capital	-3.55M

Cash Flow

In the last 12 months, operating cash flow was -125.81 million and capital expenditures 1.62 million, giving a free cash flow of -124.19 million.

Operating Cash Flow	-125.81M
Capital Expenditures	1.62M
Free Cash Flow	-124.19M
FCF Per Share	-6.77

Margins

Gross margin is 83.24%, with operating and profit margins of -85.89% and -80.61%.

Gross Margin	83.24%
Operating Margin	-85.89%
Pretax Margin	-78.81%
Profit Margin	-80.61%
EBITDA Margin	-77.11%
EBIT Margin	-85.89%
FCF Margin	n/a

Dividends & Yields

WSE:RVU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.48%
Shareholder Yield	-11.48%
Earnings Yield	-24.01%
FCF Yield	-28.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

WSE:RVU has an Altman Z-Score of 1.68 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.68
Piotroski F-Score	1